Adding Olaparib to Abiraterone Does Not Worsen HRQoL in mCRPC

Investigators studied health-related quality of life (HRQoL) and pain outcomes for patients with metastatic prostate cancer (mCRPC) taking olaparib plus abiraterone.

Related Keywords

Chicago ,Illinois ,United States ,North Carolina ,American ,Andrewj Armstrong , ,Duke Cancer Institute Center ,American Society Of Clinical Oncology ,American Society ,Clinical Oncology ,Urologic Cancer ,Functional Assessment ,Cancer Therapy ,Prostate Cancer ,Brief Pain Inventory Short Form ,